about
Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseEmodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesisToll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.Dual role of microRNAs in NAFLD.Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy.Hyper-IgM, neutropenia, mild infections and low response to polyclonal stimulation: hyper-IgM syndrome or common variable immunodeficiency?TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells.T regulatory cell number and function: the autoimmune traits in liver diseases.Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver diseaseTargeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinomaRetinoids counteract insulin resistance and liver steatosis: What's the potential mechanism?Hepatic stellate cell proliferation: A potential role of protein kinase R
P50
Q24539106-574FCDE6-1ECB-4A10-94E9-9A2AEDE22FACQ26852606-546A72EA-195A-4E3A-8102-4BAEA5D8191AQ34191208-CD8422CC-2E77-401B-A200-ABC4F07AF2A6Q34462482-910B5DC0-6E10-4632-8EB3-87BF7FCD3474Q34589665-0A363B77-BD8B-41F8-BE60-B0F2F330E3D9Q34685694-9815BE2A-A20D-4954-89D9-1B20939BF6DFQ37420964-A648E20F-2520-4F31-8F68-9F9D0176F06FQ38099737-72E0ED3C-05F5-45BC-97CC-5A5A8FF48BE3Q39629021-335C4BFF-784B-4368-A5FB-5A23CF1BC498Q41158897-41CA70C1-8AC9-4C7C-93ED-5933D68D4369Q41326837-51F34FA4-3829-450F-BE8A-1C55D5A9DA86Q50796857-66A199BA-9E90-454F-87C3-8D7E3E8E3684Q50974153-BC1EAD08-7199-4392-AE01-695F621A39ACQ51030472-2C3A9FAD-A965-4E68-8016-9F97ED6B095AQ54694045-64A86EF6-C445-4D19-BFAB-C51E28A6329BQ57803934-62ECF0FE-33D6-4D74-80F5-903592DB8DE2Q62066880-E5015B40-E2D0-4A60-B56A-E670601E37E1Q62066896-E7FECE87-CBEF-4110-9561-FE697A0598B2Q62066927-F08026EC-B42F-493E-A7AA-DB59DAA06947
P50
description
researcher ORCID ID = 0000-0001-6313-3247
@en
wetenschapper
@nl
name
Sara Ceccarelli
@ast
Sara Ceccarelli
@en
Sara Ceccarelli
@es
Sara Ceccarelli
@nl
type
label
Sara Ceccarelli
@ast
Sara Ceccarelli
@en
Sara Ceccarelli
@es
Sara Ceccarelli
@nl
prefLabel
Sara Ceccarelli
@ast
Sara Ceccarelli
@en
Sara Ceccarelli
@es
Sara Ceccarelli
@nl
P108
P106
P21
P31
P496
0000-0001-6313-3247